Hyperbaric Oxygen Therapy in HAMstring Injury (HOTHAM) Trial
NCT ID: NCT06526728
Last Updated: 2024-11-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE3
50 participants
INTERVENTIONAL
2024-10-30
2028-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. Does Hyperbaric Oxygen Therapy accelerates the time needed to return to play/-duty following hamstring injury.
2. Does Hyperbaric Oxygen Therapy decrease the amount of reinjuries within 1 year following Return to play/-duty? Besides these questions this study will clinically and radiologically evaluate the healing process over time as well as the occurrence of (serious) adverse events.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Influence of Endurance Exercise and Histamine Receptors on the Gene Expression in Skeletal Muscle
NCT05131555
The Role of Methylphenidate on Performance in the Cold
NCT04283877
Tracing Changed Production of Red Blood Cells
NCT05833477
Effect of an H1 Receptor Antagonist on Exercise Performance in Hypoxia
NCT03192488
Effects of Oxygen Status on Endotoxemia Induced Inflammation and Hypoxia Inducible Factor-1α
NCT01978158
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To Compare the time needed to return to play (RTP) or -full unrestricted duty (RTD) after seven daily sessions of HBOT to a historical control group (standard care). • Time needed to return to play (days) / time needed to return to full unrestricted duty (days) defined as:
* RTP: Number of days from initial injury until the athlete is cleared to resume full unrestricted training
* RTP: Number of days from initial injury until soldier is cleared to resume full unrestricted (physical) duty activities.
Secondary objective(s), if applicable Endpoint(s) for secondary objectives Clinically assess the hamstring injury over time (Baseline, week 2 and at RTP/RTD) • Patient reported hamstring scores: Tenger activity score, Functional Assessment scale for acute hamstring injuries and psychological readiness.
* Maximum and mean pain scores (0-10) assessed with the visual analog scale, at injury, at rest and during sprinting.
* Physical examination including:
* Palpation: Location and dimension of painful area/lesion, presence of hematoma or -swelling
* Pain with isometric contraction against resistance
* Hamstring flexibility tests: Passive straight leg raise, Active knee extension test.
* Hamstring isokinetic strength (Hand hold dynamometer) Investigate MRI changes over time (Baseline, week 2)
* MRI derived parameters: Aspect of the injury on T1 and T2-weighted images scored by a radiologist using a standardized form.
Registration of re-injury rates at 2- and 12 months following initial injury • Number of re-injury at -2 and 12 months following initial injury
Assess safety of HBOT in patients with hamstring injury
• Number of AE- and SAE from signing of informed consent to 1 week following last HBOT session.
Trial design Open-label, prospective study with matched historical control cases as comparators (case-control) where participants are treated with seven daily sessions of hyperbaric oxygen therapy followed by one year of electronic follow-up.
Trial population
The trial population will consist of 50 adult (≥18 years old) athletes and military personnel with a recent (≤7 days) clinical diagnosis of an acute hamstring injury, defined as:
* Anamnestic acute injury
* Anamnestic pain in the posterior thigh
* Localized pain during palpation of the hamstring muscle
* Localized pain during passive straight leg raise
* Increased pain during isometric contraction of the hamstring muscles. Participants will not be eligible to participate in the study if they: are not capable of doing an active exercise program, have no intention to return to full sporting or duty activities, the injury is caused by extrinsic trauma, they have a chronic or recent (\<2 months) hamstring injury, the injury is a complete proximal tendon avulsion, there are other injuries inhibiting recovery or if there are contra-indications for MRI or HBOT.
Interventions:
Following inclusion patients will be treated with seven daily sessions of HBOT. During this treatment patients are placed in a hyperbaric chamber in which 100% (pure) medicinal oxygen is breathed via a built-in breathing mask at a pressure of 2.4 times atmospheric pressure (equal to diving at a depth of 14 meters) for 90 min, including three 5 min 'air breaks' during which patients breathe air instead of oxygen. This treatment regime is standard within the AUMC and thus remains within the oxygen toxicity and non-decompression limits. .
On three occasions (baseline and week 2 and at RTP/RTD) participants will undergo physical examination. On two occasions (baseline and week 2) an MRI scan of the injured leg will be made. Participants will be monitored for the occurrence of re-injury at 2 and 12 months following return to sport or -unrestricted duty
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment Arm
Participants will be subjected to seven once-daily sessions of hyperbaric oxygen therapy.
Generic Name: Oxygen Dosage: 100% Frequency: Once-daily Duration per treatment session: 115-120 minutes
Hyperbaric oxygen
Participants will be subjected to seven once-daily sessions of hyperbaric oxygen therapy. Each session will last 115-120 minutes whereby the chambre will be pressurized to 2.4 ATA during which participants will breathe 100% (pure) oxygen.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hyperbaric oxygen
Participants will be subjected to seven once-daily sessions of hyperbaric oxygen therapy. Each session will last 115-120 minutes whereby the chambre will be pressurized to 2.4 ATA during which participants will breathe 100% (pure) oxygen.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The participant is between 18 and 65 years old
* The participant has a clinical diagnosis of an acute hamstring injury ≤7 days old, defined as:
* Anamnestic acute injury
* Anamnestic pain in the posterior thigh
* Localized pain during palpation of hamstring muscle
* Localized pain during passive straight leg raise
* Increased pain during isometric contraction
* The participant is able to start of HBOT treatment ≤7 days)
Exclusion Criteria
* The participant does not have the intention to full sporting activity or duty activities;
* The cause of the hamstring injury is an extrinsic trauma on the posterior thigh;
* The participant has a chronic hamstring injury \>2 months, defined as recurrent pain or tenderness of the hamstring;
* The current injury is a re-injury ≤2months after RTP/RTD after acute ipsilateral hamstring injury;
* Clinical suspicion of a complete proximal tendon avulsions;
* Presence of other concurrent injuries inhibiting rehabilitation;
* The participant is not able to give informed consent;
* There are contra-indications for MRI: Pacemaker, pregnancy and claustrophobia
* There are contra-indications for HBOT:
* Smoking or quit smoking \<3 months prior to injury;
* A previous spontaneous pneumothorax.
* Implantation of ICD or PM not compatible with hyperbaric pressure
* Current or recent (\<6 months) use of cytostatics
* Unable to perform a Valsalva manoeuvre to pressurize the middle ear (pre-existent ear-nose-throat complaints or a current upper airway infection).
* Pregnancy
* Claustrophobia
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
JL Tol
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
JL Tol
Professor of Sports Medicine, Principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Amsterdam UMC
Amsterdam, North Holland, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024.0395
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.